Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 142
11
Diseases
14
Unique genes
0.307
Avg. similarity score
Atrioventricular septal defect
Most-connected disease (6 links)
Disease
Searched: Holt-oram syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Holt-oram syndrome
Atrioventricular septal defect
Chromosome 8p23.1 monosomy
Congenital pulmonary valve atresia
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome
Partial atrioventricular canal defect
Testicular anomaly with congenital heart disease
Congenital heart disease with or without pancreatic hypoplasia or diabetes
Yorifuji okuno syndrome
Neurodevelopmental disorder with hypotonia and seizures
Schimke immuno-osseous dysplasia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Atrioventricular septal defect | 6 | 6 | 12 |
| Chromosome 8p23.1 monosomy | 6 | 6 | 1 |
| Congenital pulmonary valve atresia | 6 | 6 | 1 |
| Pancreatic hypoplasia-diabetes-congenital heart disease syndrome | 6 | 6 | 2 |
| Partial atrioventricular canal defect | 6 | 6 | 2 |
| Testicular anomaly with congenital heart disease | 6 | 6 | 1 |
| Congenital heart disease with or without pancreatic hypoplasia or diabetes | 5 | 5 | 1 |
| Yorifuji okuno syndrome | 5 | 5 | 4 |
| Neurodevelopmental disorder with hypotonia and seizures | 2 | 2 | 1 |
| Holt-oram syndrome | 1 | 1 | 1 |
| Schimke immuno-osseous dysplasia | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GATA4 | 8 / 11 | Atrioventricular septal defect, Chromosome 8p23.1 monosomy, Congenital heart disease with or without pancreatic hypoplasia or diabetes, Congenital pulmonary valve atresia and 4 more |
| CRELD1 | 3 / 11 | Atrioventricular septal defect, Neurodevelopmental disorder with hypotonia and seizures, Partial atrioventricular canal defect |
| GATA6 | 3 / 11 | Atrioventricular septal defect, Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, Yorifuji okuno syndrome |
| SMARCAL1 | 2 / 11 | Atrioventricular septal defect, Schimke immuno-osseous dysplasia |
| TBX5 | 2 / 11 | Atrioventricular septal defect, Holt-oram syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Physiological factors | Reactome | 2 / 12 | 143× | 8.27e-5 | 1.63e-3 ✓ sig. |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | Reactome | 2 / 14 | 123× | 1.14e-4 | 2.10e-3 ✓ sig. |
| Regulation of gap junction activity | Reactome | 1 / 3 | 286× | 3.49e-3 | 2.83e-2 ✓ sig. |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | Reactome | 1 / 3 | 286× | 3.49e-3 | 2.83e-2 ✓ sig. |
| Factors involved in megakaryocyte development and platelet production | Reactome | 2 / 99 | 17.3× | 5.74e-3 | 4.00e-2 ✓ sig. |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | Reactome | 1 / 7 | 123× | 8.13e-3 | 5.01e-2 |
| RHO GTPases activate CIT | Reactome | 1 / 8 | 107× | 9.29e-3 | 5.43e-2 |
| Formation of annular gap junctions | Reactome | 1 / 11 | 78.0× | 1.28e-2 | 6.57e-2 |
| Gap junction degradation | Reactome | 1 / 12 | 71.5× | 1.39e-2 | 6.94e-2 |
| Activation of Ca-permeable Kainate Receptor | Reactome | 1 / 12 | 71.5× | 1.39e-2 | 6.94e-2 |
| cGMP-PKG signaling pathway | KEGG | 2 / 166 | 10.3× | 1.55e-2 | 7.40e-2 |
| LGI-ADAM interactions | Reactome | 1 / 14 | 61.3× | 1.62e-2 | 7.59e-2 |
| Trafficking of AMPA receptors | Reactome | 1 / 17 | 50.5× | 1.96e-2 | 8.49e-2 |
| Transcriptional regulation of pluripotent stem cells | Reactome | 1 / 17 | 50.5× | 1.96e-2 | 8.49e-2 |
| Gap junction assembly | Reactome | 1 / 18 | 47.7× | 2.08e-2 | 8.77e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| atrioventricular canal development | GO:0036302 | 3 / 11 | 364× | 5.50e-8 | 7.68e-6 ✓ sig. |
| endocardial cushion development | GO:0003197 | 3 / 13 | 308× | 9.53e-8 | 1.22e-5 ✓ sig. |
| cardiac muscle cell differentiation | GO:0055007 | 3 / 30 | 133× | 1.34e-6 | 1.09e-4 ✓ sig. |
| positive regulation of cardiac muscle cell proliferation | GO:0060045 | 3 / 32 | 125× | 1.64e-6 | 1.29e-4 ✓ sig. |
| regulation of DNA-templated transcription | GO:0006355 | 8 / 1,454 | 7.3× | 2.59e-6 | 1.86e-4 ✓ sig. |
| NMDA selective glutamate receptor signaling pathway | GO:0098989 | 2 / 6 | 445× | 7.80e-6 | 4.51e-4 ✓ sig. |
| atrioventricular node development | GO:0003162 | 2 / 6 | 445× | 7.80e-6 | 4.51e-4 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 7 / 1,208 | 7.7× | 1.06e-5 | 5.70e-4 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 6 / 778 | 10.3× | 1.15e-5 | 6.07e-4 ✓ sig. |
| sinoatrial node development | GO:0003163 | 2 / 8 | 334× | 1.46e-5 | 7.28e-4 ✓ sig. |
| skeletal muscle tissue development | GO:0007519 | 3 / 68 | 58.9× | 1.63e-5 | 7.92e-4 ✓ sig. |
| intestinal epithelial cell differentiation | GO:0060575 | 2 / 11 | 243× | 2.86e-5 | 1.20e-3 ✓ sig. |
| heart development | GO:0007507 | 4 / 273 | 19.6× | 3.97e-5 | 1.55e-3 ✓ sig. |
| atrial septum morphogenesis | GO:0060413 | 2 / 13 | 205× | 4.05e-5 | 1.57e-3 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 6 / 1,002 | 8.0× | 4.85e-5 | 1.80e-3 ✓ sig. |